Search

Climate change is real – it’s happening now – and it will take an awesome effort from the pharma industry to mitigate it

Nominations are open now – but only until October 10.

Studying the link between Alzheimer’s risk, estrogen levels, and menopausal status in women

Perrigo’s Opill receives FDA approval following unanimous support from advisory committees

How scientists extracted a treatment for episodic ataxia from traditional Kwakwaka'wakw medicine

Researchers demonstrate that microRNA-132 can significantly affect different brain cells, with potential implications for Alzheimer’s disease.

Adcendo signs antibody drug conjugate licensing deal with DualityBio.

The world needs new medicines to treat obesity-related conditions. Here’s what researchers at the UK’s University of Birmingham are doing about it.

The science behind space-based medicine is a bit of a slow-burner, but it’s on the launchpad

Both the FDA and Pfizer have released statements in the aftermath of the North Carolina tornado.